Dopamine Uptake Inhibitors

"Dopamine Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.

Descriptor ID	D018765
MeSH Number(s)	D27.505.519.562.437.220 D27.505.519.625.150.800 D27.505.519.625.600.220 D27.505.696.577.150.800 D27.505.696.577.600.220
Concept/Terms	Dopamine Uptake Inhibitors Dopamine Uptake Inhibitors Reuptake Inhibitors, Dopamine Inhibitors, Dopamine Uptake Uptake Inhibitors, Dopamine Inhibitors, Dopamine Reuptake Dopamine Reuptake Inhibitors

Below are MeSH descriptors whose meaning is more general than "Dopamine Uptake Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Membrane Transport Modulators [D27.505.519.562]
Neurotransmitter Uptake Inhibitors [D27.505.519.562.437]
Dopamine Uptake Inhibitors [D27.505.519.562.437.220]
Neurotransmitter Agents [D27.505.519.625]
Dopamine Agents [D27.505.519.625.150]
Dopamine Uptake Inhibitors [D27.505.519.625.150.800]
Neurotransmitter Uptake Inhibitors [D27.505.519.625.600]
Dopamine Uptake Inhibitors [D27.505.519.625.600.220]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Dopamine Agents [D27.505.696.577.150]
Dopamine Uptake Inhibitors [D27.505.696.577.150.800]
Neurotransmitter Uptake Inhibitors [D27.505.696.577.600]
Dopamine Uptake Inhibitors [D27.505.696.577.600.220]

Below are MeSH descriptors whose meaning is related to "Dopamine Uptake Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Dopamine Uptake Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Dopamine Uptake Inhibitors" by people in this website by year, and whether "Dopamine Uptake Inhibitors" was a major or minor topic of these publications.

Bar chart showing 112 publications over 25 distinct years, with a maximum of 11 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	2	2
1995	0	1	1
1997	0	1	1
1998	2	1	3
1999	2	1	3
2000	0	1	1
2001	1	0	1
2002	2	1	3
2003	6	0	6
2004	1	0	1
2005	0	2	2
2006	2	3	5
2007	7	3	10
2008	2	5	7
2009	1	2	3
2010	5	0	5
2011	4	3	7
2012	6	3	9
2013	5	3	8
2014	3	2	5
2015	2	2	4
2016	3	1	4
2017	5	6	11
2018	4	2	6
2019	3	1	4

Below are the most recent publications written about "Dopamine Uptake Inhibitors" by people in Profiles.

Aksenova M, Sybrandt J, Cui B, Sikirzhytski V, Ji H, Odhiambo D, Lucius MD, Turner JR, Broude E, Peña E, Lizarraga S, Zhu J, Safro I, Wyatt MD, Shtutman M. Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation. J Neuroimmune Pharmacol. 2020 06; 15(2):209-223.

View in: PubMed
Pati S, Angel P, Drake RR, Wagner JJ, Cummings BS. Lipidomic changes in the rat hippocampus following cocaine conditioning, extinction, and reinstatement of drug-seeking. Brain Behav. 2019 12; 9(12):e01451.

View in: PubMed
Penrod RD, Thomsen M, Taniguchi M, Guo Y, Cowan CW, Smith LN. The activity-regulated cytoskeleton-associated protein, Arc/Arg3.1, influences mouse cocaine self-administration. Pharmacol Biochem Behav. 2020 01; 188:172818.

View in: PubMed
Roberts-Wolfe DJ, Heinsbroek JA, Spencer SM, Bobadilla AC, Smith ACW, Gipson CD, Kalivas PW. Transient synaptic potentiation in nucleus accumbens shell during refraining from cocaine seeking. Addict Biol. 2020 05; 25(3):e12759.

View in: PubMed
Siemsen BM, Giannotti G, McFaddin JA, Scofield MD, McGinty JF. Biphasic effect of abstinence duration following cocaine self-administration on spine morphology and plasticity-related proteins in prelimbic cortical neurons projecting to the nucleus accumbens core. Brain Struct Funct. 2019 Mar; 224(2):741-758.

View in: PubMed
Li C, White AC, Schochet T, McGinty JF, Frantz KJ. ARC and BDNF expression after cocaine self-administration or cue-induced reinstatement of cocaine seeking in adolescent and adult male rats. Addict Biol. 2018 11; 23(6):1233-1241.

View in: PubMed
Weber RA, Logan CN, Leong KC, Peris J, Knackstedt L, Reichel CM. Regionally Specific Effects of Oxytocin on Reinstatement of Cocaine Seeking in Male and Female Rats. Int J Neuropsychopharmacol. 2018 07 01; 21(7):677-686.

View in: PubMed
Bobadilla AC, Garcia-Keller C, Chareunsouk V, Hyde J, Medina Camacho D, Heinsbroek JA, Kalivas PW. Accumbens brain-derived neurotrophic factor (BDNF) transmission inhibits cocaine seeking. Addict Biol. 2019 09; 24(5):860-873.

View in: PubMed
Hodebourg R, Murray JE, Fouyssac M, Puaud M, Everitt BJ, Belin D. Heroin seeking becomes dependent on dorsal striatal dopaminergic mechanisms and can be decreased by N-acetylcysteine. Eur J Neurosci. 2019 08; 50(3):2036-2044.

View in: PubMed
Huber R, Imeh-Nathaniel A, Nathaniel TI, Gore S, Datta U, Bhimani R, Panksepp JB, Panksepp J, van Staaden MJ. Drug-sensitive Reward in Crayfish: Exploring the Neural Basis of Addiction with Automated Learning Paradigms. Behav Processes. 2018 Jul; 152:47-53.

View in: PubMed

People

Explore

Similar Concepts

Top Journals